[go: up one dir, main page]

CO4810375A1 - Derivados de 9-amino-3-ceto eritromicina - Google Patents

Derivados de 9-amino-3-ceto eritromicina

Info

Publication number
CO4810375A1
CO4810375A1 CO98063687A CO98063687A CO4810375A1 CO 4810375 A1 CO4810375 A1 CO 4810375A1 CO 98063687 A CO98063687 A CO 98063687A CO 98063687 A CO98063687 A CO 98063687A CO 4810375 A1 CO4810375 A1 CO 4810375A1
Authority
CO
Colombia
Prior art keywords
derivatives
amino
compounds
formula
erythromycin
Prior art date
Application number
CO98063687A
Other languages
English (en)
Inventor
Wu Yong-Jin
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CO4810375A1 publication Critical patent/CO4810375A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA I. Y SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, EN LAS QUE R1,R2,R3,R4 Y X SON COMO SE HAN DEFINIDO EN ESTE DOCUMENTO. LA INVENCION TAMBIEN SE REFIERE A COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS COMPUESTOS DE FORMULA I A PROCEDIMIENTOS PARA USAR DICHOS COMPUESTOS DE FORMULA I EN EL TRATAMIENTO DE INFECCIONES Y A PROCEDIMIENTOS PARA PREPARAR DICHOS COMPUESTOS DE FORMULA I.
CO98063687A 1997-10-29 1998-10-29 Derivados de 9-amino-3-ceto eritromicina CO4810375A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6367697P 1997-10-29 1997-10-29

Publications (1)

Publication Number Publication Date
CO4810375A1 true CO4810375A1 (es) 1999-06-30

Family

ID=22050768

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98063687A CO4810375A1 (es) 1997-10-29 1998-10-29 Derivados de 9-amino-3-ceto eritromicina

Country Status (13)

Country Link
US (1) US6159945A (es)
AP (1) AP9801378A0 (es)
AR (1) AR017177A1 (es)
AU (1) AU9277698A (es)
CO (1) CO4810375A1 (es)
GT (1) GT199800163A (es)
HN (1) HN1998000159A (es)
HR (1) HRP980571A2 (es)
MA (1) MA26558A1 (es)
PA (1) PA8461701A1 (es)
PE (1) PE122499A1 (es)
TN (1) TNSN98194A1 (es)
WO (1) WO1999021866A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
US6248719B1 (en) 1998-06-03 2001-06-19 Pfizer Inc Tricyclic 3-keto derivatives of 6-O-methylerthromycin
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
AU6484199A (en) * 1998-12-10 2000-06-26 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
OA11753A (en) 1999-01-27 2005-07-19 Pfizer Prod Inc Ketolide antibiotics.
KR20020016799A (ko) * 1999-05-24 2002-03-06 데이비드 존 우드 13-메틸-에리트로마이신 유도체
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
US6498146B1 (en) * 1999-10-28 2002-12-24 Pfizer Inc Erythromycin derivatives
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
WO2005091967A2 (en) * 2004-03-03 2005-10-06 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
CA2591746A1 (en) 2004-12-21 2006-06-29 Pfizer Products Inc. Macrolides
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2010048600A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr) 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
EP2571506B1 (en) 2010-05-20 2017-05-10 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
MX356772B (es) 2013-03-15 2018-06-13 Cempra Pharmaceuticals Inc Procesos convergentes para la preparacion de agentes antibacterianos macrolidos.
CN105246334A (zh) 2013-04-04 2016-01-13 哈佛大学的校长及成员们 大环内酯及其制备和使用方法
HK1242920A1 (zh) 2014-10-08 2018-07-06 哈佛大学的校长及成员们 14-元酮内酯及其制备和使用方法
WO2016154591A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US6060234A (en) * 1991-01-17 2000-05-09 Abbott Laboratories Polyketide derivatives and recombinant methods for making same
ATE145212T1 (de) * 1992-04-22 1996-11-15 Taisho Pharmaceutical Co Ltd 5-0-desosaminylerythronolide a derivate
AU6932098A (en) * 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
PL337606A1 (en) * 1997-06-11 2000-08-28 Pfizer Prod Inc Derivatives of erythromycin 9-oxime

Also Published As

Publication number Publication date
MA26558A1 (fr) 2004-12-20
AU9277698A (en) 1999-05-17
WO1999021866A1 (en) 1999-05-06
PE122499A1 (es) 1999-12-02
AR017177A1 (es) 2001-08-22
TNSN98194A1 (fr) 2005-03-15
HN1998000159A (es) 1999-02-09
US6159945A (en) 2000-12-12
GT199800163A (es) 2000-04-15
AP9801378A0 (en) 2000-04-29
PA8461701A1 (es) 2000-05-24
HRP980571A2 (en) 1999-08-31

Similar Documents

Publication Publication Date Title
CO4810375A1 (es) Derivados de 9-amino-3-ceto eritromicina
PA8495101A1 (es) Derivados de 13-metileritromicina
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
PA8547701A1 (es) Nucleosidos 4 substituidos.
UY28510A1 (es) Compuestos quimicos
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
PA8442001A1 (es) Derivados de pirimidina biciclica condensada
PA8591701A1 (es) Derivados de pirrolopirimidina
UY26872A1 (es) Derivados de la 4- fenil piridina
PA8551001A1 (es) Nuevos compuestos
AR029634A1 (es) Compuestos derivados heterociclicos utiles como agentes anticancerosos, composicion farmaceutica y procedimiento de tratamiento
DK2314582T3 (da) Heterocykliske forbindelser som antivirusmidler
PA8472301A1 (es) Derivados de isotiazol utiles como agentes anticancerosos
SV2002000504A (es) Derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal ref.pc10760/20205/bb
AR029766A1 (es) Compuesto inhibidor de quinasa y uso del mismo para preparar una composicion farmaceutica
AR037517A1 (es) Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
ATE386725T1 (de) Heterocyclylverbindungen
PA8576001A1 (es) "difenilazetidinonas sustituidas en anillo, procedimiento para su preparacion , medicamentos que comprenden estos compuestos y su uso".
ECSP045420A (es) Derivados de benzoxazina como moduladores 5-ht6 y usos de los mismos
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.
CO4810376A1 (es) Derivados de eritromicina triciclicos
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos